Release Date: 27/08/12 09:03 Summary: HY 2012 - Appendix 4D & Consolidated Financial Accounts Price Sensitive: Yes Download Document 2.22MB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status